Middle East and Africa collagen supplements market is expected to reach USD USD 81,525.40 thousand by 2030 from USD 62,937.85 thousand in 2022, growing at a CAGR of 3.4% during the forecast period of 2023 to 2033.
Market Segmentation
Middle East and Africa collagen Supplements Market, By Nature (Gelatin, Hydrolyzed Collagen, Native Collagen, and Others), Source (Animal-Based, Plant-Based, and Marine-Based), Product (Powder, Tablets, Capsules, Liquid, Soft Gels, Gummies, Gel Caps, and Others), Collagen Type (Type I, Type II, Type III, And Type IV), Function (Skincare, Bone & Joint Health, Immunity Function, Diabetes, Exercise and Athletic Performance, Cardiac Health, Mental Health, and Others), Packaging (Rigid Containers/Jars, Pouches & Sachets, Bottles, Cardboard Boxes and Others), Distribution Channel (Store-Based Retailers and Non-Store Retailers), Country (Brazil, Argentina, and Rest of South America,) - Industry Trends and Forecast to 2030
Overview of Middle East and Africa Collagen Supplements Market Dynamics
Drivers
Increasing use of collagen supplements in treatment procedure of bone diseases
Increasing knowledge and awareness about the health benefits of collagen supplements.
Restraints
Regulations upon the slaughtering of farm and poultry animals
Possible side effects
Opportunity
Rising use of collagen supplements among sports athletes
Market Players
Some of the major market players operating in the Middle East and Africa collagen supplements market are:
Orgain Inc.
Essential elements
HUM Nutrition Inc.
ReFa USA
BUBS Naturals
ITALGEL S.r.l.
Sports Research Corporation
Agent Nateur
Nanotech
LABSMED
Hemant Surgical Industries Ltd
Others
TABLE OF CONTENTS
1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA COLLAGEN SUPPLEMENTS MARKET 15
1.4 LIMITATIONS 17
1.5 MARKETS COVERED 17
2 MARKET SEGMENTATION 20
2.1 MARKETS COVERED 20
2.2 GEOGRAPHICAL SCOPE 21
2.3 YEARS CONSIDERED FOR THE STUDY 22
2.4 CURRENCY AND PRICING 22
2.5 DBMR TRIPOD DATA VALIDATION MODEL 23
2.6 MULTIVARIATE MODELLING 26
2.7 NATURE LIFELINE CURVE 26
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 27
2.9 DBMR MARKET POSITION GRID 28
2.10 VENDOR SHARE ANALYSIS 29
2.11 SECONDARY SOURCES 30
2.12 ASSUMPTIONS 30
3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 34
4.1 SUPPLY CHAIN ANALYSIS 35
4.2 INDUSTRY TRENDS AND FUTURE PERSPECTIVES 35
4.3 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 36
4.4 FACTORS INFLUENCING PURCHASING DECISION 37
4.5 SHOPPING BEHAVIOUR AND DYNAMICS 38
4.5.1 RECOMMENDATION FROM FAMILY AND FRIENDS - 38
4.5.2 RESEARCH 38
4.5.3 IMPULSIVE 38
4.5.4 ADVERTISEMENTS 38
4.6 NEW PRODUCT LAUNCH STRATEGY 39
4.7 CONSUMER DISPOSABLE INCOME DYNAMICS/ SPEND DYNAMICS 39
4.8 PRODUCTION AND CONSUMPTION PATTERN 39
4.9 IMPORT-EXPORT ANALYSIS 40
4.10 SPECIFICATIONS FOR MANUFACTURING AND DISTRIBUTING COLLAGEN SUPPLEMENTS AND POWDERS 40
4.10.1 MIDDLE EAST & AFRICA COLLAGEN SUPPLEMENTS MARKET, REGULATIONS 45
4.11 PORTER'S FIVE FORCES MODEL 50
5 MIDDLE EAST & AFRICA COLLAGEN SUPPLEMENTS MARKET, PRICING ANALYSIS 51
6 MIDDLE EAST & AFRICA COLLAGEN SUPPLEMENTS MARKET, BRAND OUTLOOK 53
7 MARKET OVERVIEW 54
7.1 DRIVERS 56
7.1.1 INCREASING USE OF COLLAGEN SUPPLEMENTS IN TREATMENT PROCEDURE OF BONE DISEASES 56
7.1.2 INCREASING KNOWLEDGE AND AWARENESS ABOUT THE HEALTH BENEFITS OF COLLAGEN SUPPLEMENTS 56
7.1.3 INCREASING USE OF COLLAGEN SUPPLEMENTS FOR COSMETIC PURPOSES 57
7.2 RESTRAINTS 58
7.2.1 REGULATIONS UPON THE SLAUGHTERING OF FARM AND POULTRY ANIMALS 58
7.2.2 POSSIBLE SIDE EFFECTS 58
7.3 OPPORTUNITIES 59
7.3.1 RISING USE OF COLLAGEN SUPPLEMENTS AMONG SPORTS ATHLETES 59
7.3.2 PRODUCT INNOVATION & LAUNCHES 60
7.4 CHALLENGES 61
7.4.1 LOW PENETRATION OF COLLAGEN SUPPLEMENTS IN DEVELOPING REGIONS POSES A SUBSTANTIAL CHALLENGE 61
7.4.2 ETHICAL AND SUSTAINABLE SOURCING CONCERNS 62
8 MIDDLE EAST & AFRICA COLLAGEN SUPPLEMENT MARKET, BY NATURE 63
8.1 OVERVIEW 64
8.2 GELATIN 67
8.3 HYDROLYZED COLLAGEN 67
8.4 NATIVE COLLAGEN 67
8.5 OTHERS 68
9 MIDDLE EAST & AFRICA COLLAGEN SUPPLEMENTS MARKET, BY SOURCE 69
9.1 OVERVIEW 70
9.2 ANIMAL-BASED 73
9.2.1 BOVINE 73
9.2.1.1 CATTLES 74
9.2.1.2 BUFFALOES 74
9.2.1.3 OTHERS 74
9.2.2 POLUTRY 74
9.2.2.1 CHICKEN 75
9.2.2.2 TURKEY 75
9.2.2.3 OTHERS 75
9.2.3 OTHERS 75
9.3 MARINE-BASED 75
9.3.1 FISHES 76
9.3.2 SEAWEEDS/ALGAES 76
9.3.3 OTHERS 76
9.4 PLANT-BASED 76
10 MIDDLE EAST & AFRICA COLLAGEN SUPPLEMENT MARKET, BY PRODUCT 77
10.1 OVERVIEW 78
10.2 POWDER 81
10.3 TABLETS 81
10.4 CAPSULES 81
10.5 LIQUID 82
10.6 SOFT GELS 82
10.7 GUMMIES 83
10.8 GEL CAPS 83
10.9 OTHERS 84
11 MIDDLE EAST & AFRICA COLLAGEN SUPPLEMENT MARKET, BY COLLAGEN TYPE 85
11.1 OVERVIEW 86
11.2 TYPE I 89
11.3 TYPE III 89
11.4 TYPE II 89
11.5 TYPE IV 90
12 MIDDLE EAST & AFRICA COLLAGEN SUPPLEMENT MARKET, BY FUNCTION 91
12.1 OVERVIEW 92
12.2 SKINCARE 95
12.3 BONE & JOINT HEALTH 95
12.4 IMMUNITY FUNCTION 95
12.5 DIABETES 96
12.6 EXERCISE AND ATHLETIC PERFORMANCE 96
12.7 CARDIAC HEALTH 97
12.8 MENTAL HEALTH 97
12.9 OTHERS 98
13 MIDDLE EAST & AFRICA COLLAGEN SUPPLEMENTS MARKET, BY PACKAGING 99
13.1 OVERVIEW 100
13.2 RIGID CONTAINERS/JARS 103
13.3 POUCHES & SACHETS 103
13.4 BOTTLES 103
13.5 CARDBOARD BOXES 104
14 MIDDLE EAST & AFRICA COLLAGEN SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL 105
14.1 OVERVIEW 106
14.2 STORE BASED RETAILERS 109
14.2.1 SUPERMARKETS/HYPERMARKETS 109
14.2.2 DRUG AND PHARMACY STORE 109
14.2.3 MULTI-BRAND STORES 110
14.2.4 MONO-BRAND STORES 110
14.2.5 OTHERS 110
14.3 NON-STORE BASED RETAILERS 110
14.3.1 E-COMMERCE PLATFORMS 111
14.3.2 COMPANY WEBSITES 111
15 MIDDLE EAST & AFRICA COLLAGEN SUPPLEMENT MARKET, BY REGION 112
15.1 MIDDLE EAST AND AFRICA 113
15.1.1 SOUTH AFRICA 118
15.1.2 UAE 118
15.1.3 SAUDI ARABIA 118
15.1.4 KUWAIT 118
15.1.5 REST OF MIDDLE EAST AND AFRICA 118
16 MIDDLE EAST & AFRICA COLLAGEN SUPPLEMENTS MARKET: COMPANY LANDSCAPE 119
16.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 119
17 SWOT 120
18 MIDDLE EAST & AFRICA COLLAGEN SUPPLEMENTS MARKET, COMPANY PROFILES 121
18.1 ROUSSELOT (A SUBSIDIARY OF DARLING INGREDIENTS) 121
18.1.1 COMPANY SNAPSHOT 121
18.1.2 REVENUE ANALYSIS 121
18.1.3 COMPANY SHARE ANALYSIS 122
18.1.4 PRODUCT PORTFOLIO 122
18.1.5 RECENT DEVELOPMENT 122
18.2 GELITA AG 123
18.2.1 COMPANY SNAPSHOT 123
18.2.2 COMPANY SHARE ANALYSIS 123
18.2.3 PRODUCT PORTFOLIO 124
18.2.4 RECENT DEVELOPMENT 124
18.3 TCI CO., LTD. 125
18.3.1 COMPANY SNAPSHOT 125
18.3.2 REVENUE ANALYSIS 125
18.3.3 COMPANY SHARE ANALYSIS 126
18.3.4 PRODUCT PORTFOLIO 126
18.3.5 RECENT DEVELOPMENT 126
18.4 ORGAIN INC. 127
18.4.1 COMPANY SNAPSHOT 127
18.4.2 COMPANY SHARE ANALYSIS 127
18.4.3 PRODUCT PORTFOLIO 128
18.4.4 RECENT DEVELOPMENT 128
18.5 NITTA GELATIN INC. 129
18.5.1 COMPANY SNAPSHOT 129
18.5.2 REVENUE ANALYSIS 129
18.5.3 COMPANY SHARE ANALYSIS 130
18.5.4 PRODUCT PORTFOLIO 130
18.5.5 RECENT DEVELOPMENTS 130
18.6 AGENT NATEUR 131
18.6.1 COMPANY SNAPSHOT 131
18.6.2 PRODUCT PORTFOLIO 131
18.6.3 RECENT DEVELOPMENT 131
18.7 BUBS NATURALS 132
18.7.1 COMPANY SNAPSHOT 132
18.7.2 PRODUCT PORTFOLIO 132
18.7.3 RECENT DEVELOPMENT 132
18.8 ESSENTIAL ELEMENTS 133
18.8.1 COMPANY SNAPSHOT 133
18.8.2 PRODUCT PORTFOLIO 133
18.8.3 RECENT DEVELOPMENT 133
18.9 HUM NUTRITION INC. 134
18.9.1 COMPANY SNAPSHOT 134
18.9.2 PRODUCT PORTFOLIO 134
18.9.3 RECENT DEVELOPMENT 134
18.10 ITALGEL S.R.L. 135
18.10.1 COMPANY SNAPSHOT 135
18.10.2 PRODUCT PORTFOLIO 135
18.10.3 RECENT DEVELOPMENT 135
18.11 NORDIC NATURALS 136
18.11.1 COMPANY SNAPSHOT 136
18.11.2 PRODUCT PORTFOLIO 136
18.11.3 RECENT DEVELOPMENT 136
18.12 REFA USA 137
18.12.1 COMPANY SNAPSHOT 137
18.12.2 PRODUCT PORTFOLIO 137
18.12.3 RECENT DEVELOPMENT 137
18.13 RENEW LIFE FORMULAS, LLC. (A SUBSIDIARY OF THE CLOROX COMPANY) 138
18.13.1 COMPANY SNAPSHOT 138
18.13.2 REVENUE ANALYSIS 138
18.13.3 PRODUCT PORTFOLIO 139
18.13.4 RECENT DEVELOPMENT 139
18.14 SKINNY FIT, LLC. 140
18.14.1 COMPANY SNAPSHOT 140
18.14.2 PRODUCT PORTFOLIO 140
18.14.3 RECENT DEVELOPMENT 140
18.15 SPORTS RESEARCH CORPORATION 141
18.15.1 COMPANY SNAPSHOT 141
18.15.2 PRODUCT PORTFOLIO 141
18.15.3 RECENT DEVELOPMENT 142
18.16 VITAL PROTEINS LLC. (A SUBSIDIARY OF NESTLE HEALTH SCIENCE) 143
18.16.1 COMPANY SNAPSHOT 143
18.16.2 REVENUE ANALYSIS 143
18.16.3 PRODUCT PORTFOLIO 144
18.16.4 RECENT DEVELOPMENT 144
19 QUESTIONNAIRE 145
20 RELATED REPORTS 149